Countries with high deaths due to flu and tuberculosis demonstrate lower COVID-19 mortality: roles of vaccinations

References

• Singhal TA. Review of coronavirus disease-2019 (COVID-19). Indian J Pediatr. 2020;87:281–86. doi:10.1007/s12098-020-03263-6.
   PubMed Web of Science ®Google Scholar
• Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55:105924. doi:10.1016/j.ijantimicag.2020.105924.
   PubMed Web of Science ®Google Scholar
• Rubin EJ, Baden LR, Morrissey S. Audio interview: making decisions about Covid-19 testing and treatment for your patients. N Engl J Med. 2020;382:e25. doi:10.1056/NEJMe2004856.
   PubMedGoogle Scholar
• Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, Li B, Huang C-L, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–73. doi:10.1038/s41586-020-2012-7.
   PubMed Web of Science ®Google Scholar
• Cao Y, Li L, Feng Z, Wan S, Huang P, Sun X, Wen F, Huang X, Ning G, Wang W. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discovery. 2020;6:11. doi:10.1038/s41421-020-0147-1.
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–80.
   PubMed Web of Science ®Google Scholar
• Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S, van der Meer F, Kallio K, Kaya T, Anastasina M, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science (New York, N.Y.). 2020 370;eabd2985. Advance online publication. doi: 10.1126/science.abd2985
   Web of Science ®Google Scholar
• Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, Ou CQ, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55:2000547. doi:10.1183/13993003.00547-2020.
   PubMed Web of Science ®Google Scholar
• Koh WC, Naing L, Wong J. Estimating the impact of physical distancing measures in containing COVID-19: an empirical analysis. Int J Infect Dis. 2020;100:42–49. doi:10.1016/j.ijid.2020.08.026.
   PubMed Web of Science ®Google Scholar
• Liu Y, Mao B, Liang S, Yang JW, Lu HW, Chai YH, Wang L, Zhang L, Li Q-H, Zhao L, et al. Association between age and clinical characteristics and outcomes of COVID-19. Eur Respir J. 2020;55:2001112. doi:10.1183/13993003.01112-2020.
   PubMed Web of Science ®Google Scholar
• Mandal CC, Panwar MS. Can the summer temperatures reduce COVID-19 cases? Public Health. 2020;185:72–79. doi:10.1016/j.puhe.2020.05.065.
   PubMed Web of Science ®Google Scholar
• Qi H, Xiao S, Shi R, Ward MP, Chen Y, Tu W, Su Q, Wang W, Wang X, Zhang Z, et al. COVID-19 transmission in Mainland China is associated with temperature and humidity: a time-series analysis. Sci Total Environ. 2020;728:138778. doi:10.1016/j.scitotenv.2020.138778.
   PubMed Web of Science ®Google Scholar
• Rathore APS, St John AL. Cross-reactive immunity among flaviviruses. Front Immunol. 2020;11:334. doi:10.3389/fimmu.2020.00334.
   PubMed Web of Science ®Google Scholar
• Ahmed AE. Incidence of coronavirus disease (COVID-19) and countries affected by malarial infections. Travel Med Infect Dis. 2020;101693. doi:10.1016/j.tmaid.2020.101693.
   PubMed Web of Science ®Google Scholar
• Zimmermann P, Curtis N. The influence of BCG on vaccine responses - a systematic review. Expert Rev Vaccines. 2018;17:547–54. doi:10.1080/14760584.2018.1483727.
   PubMed Web of Science ®Google Scholar
• Kleinnijenhuis J, Quintin J, Preijers F, Benn CS, Joosten LA, Jacobs C, Van Loenhout J, Xavier RJ, Aaby P, van der Meer JWM, et al. Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity. J Innate Immun. 2014;6:152–58. doi:10.1159/000355628.
   PubMed Web of Science ®Google Scholar
• Arts RJW, Moorlag S, Novakovic B, Li Y, Wang SY, Oosting M, Kumar V, Xavier RJ, Wijmenga C, Joosten LAB, et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe. 2018;23:89–100.e5. doi:10.1016/j.chom.2017.12.010.
   PubMed Web of Science ®Google Scholar
• Mourits VP, Koeken VACM, Lcj DB, Moorlag SJCFM, Chu WC, Xu X, Dijkstra H, Lemmers H, Joosten LAB, Wang Y, et al. BCG-induced trained immunity in healthy individuals: the effect of plasma muramyl dipeptide concentrations. J Immunol Res. 2020;2020:5812743. doi:10.1155/2020/5812743.
   PubMed Web of Science ®Google Scholar
• Hartmann W, Brunn ML, Stetter N, Gagliani N, Muscate F, Stanelle-Bertram S, Gabriel G, Breloer M. Helminth infections suppress the efficacy of vaccination against seasonal influenza. Cell Rep. 2019;29:2243–2256.e4. doi:10.1016/j.celrep.2019.10.051.
   PubMed Web of Science ®Google Scholar
• Mereckiene J, Cotter S, Nicoll A, Lopalco P, Noori T, Weber J, D’Ancona F, Levy-Bruhl D, Dematte L, Giambi C, et al. Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11). Euro Surveillance. 2014;19:20780. doi:10.2807/1560-7917.es2014.19.16.20780.
   PubMedGoogle Scholar
• Rosano A, Bella A, Gesualdo F, Acampora A, Pezzotti P, Marchetti S, Ricciardi W, Rizzo C. Investigating the impact of influenza on excess mortality in all ages in Italy during recent seasons (2013/14-2016/17 seasons). Int J Infect Dis. 2019;88:127–34. doi:10.1016/j.ijid.2019.08.003.
   PubMed Web of Science ®Google Scholar
• Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, The PM. BCG world atlas: a database of global BCG vaccination policies and practices. PLoS Med. 2011;8(3):e1001012. doi:10.1371/journal.pmed.1001012.
   PubMed Web of Science ®Google Scholar
• Muraille E. The unspecific side of acquired immunity against infectious disease: causes and consequences. Front Microbiol. 2016;6:1525. doi:10.3389/fmicb.2015.01525.
   PubMed Web of Science ®Google Scholar
• Kumar N, Sharma S, Barua S, Tripathi BN, Rouse BT. Virological and immunological outcomes of coinfections. Clin Microbiol Rev. 2018;31:e00111–17.
   PubMed Web of Science ®Google Scholar
• Zou Z, Yan Y, Shu Y, Gao R, Sun Y, Li X, Ju X, Liang Z, Liu Q, Zhao Y, et al. Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections. Nat Commun. 2014;5(1):3594. doi:10.1038/ncomms4594.
   PubMed Web of Science ®Google Scholar
• Nickbakhsh S, Mair C, Matthews L, Reeve R, Johnson PCD, Thorburn F, Von Wissmann B, Reynolds A, McMenamin J, Gunson RN, et al. Virus-virus interactions impact the population dynamics of influenza and the common cold. Proc Natl Acad Sci U S A. 2019;116:27142–50. doi:10.1073/pnas.1911083116.
   PubMed Web of Science ®Google Scholar
• Wolff GG. Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season. Vaccine. 2020;38:350–54. doi:10.1016/j.vaccine.2019.10.005.
   PubMed Web of Science ®Google Scholar
• Smetana J, Chlibek R, Shaw J, Splino M, Prymula R. Influenza vaccination in the elderly. Hum Vaccin Immunother. 2018;14:540–49. doi:10.1080/21645515.2017.1343226.
   PubMed Web of Science ®Google Scholar
• Marín-Hernández D, Schwartz RE, Nixon DF. Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy. J Med Virol. 2020. doi:10.1002/jmv.26120. Advance online publication.
   PubMed Web of Science ®Google Scholar
• Hsieh WY, Kuan TC, Cheng KS, Liao YC, Chen MY, Lin PH, Hsu YC, Huang CY, Hsu WH, Yu SY, et al. ACE/ACE2 ratio and MMP-9 activity as potential biomarkers in tuberculous pleural effusions . Int J Biol Sci. 2012;8:1197–205. doi:10.7150/ijbs.5087.
   PubMed Web of Science ®Google Scholar
• Rakshit S, Ponnusamy M, Papanna S, Saha B, Ahmed A, Nandi D. Immunotherapeutic efficacy of Mycobacterium indicus pranii in eliciting anti-tumor T cell responses: critical roles of IFNγ. Int J Cancer. 2012;130:865–75. doi:10.1002/ijc.26099.
   PubMed Web of Science ®Google Scholar
• Soares KC, Zheng L, Edil B, Jaffee EM. Vaccines for pancreatic cancer. Cancer J. 2012;18:642–52. (Sudbury, Mass.). doi:10.1097/PPO.0b013e3182756903.
   PubMed Web of Science ®Google Scholar
• Podder S, Rakshit S, Ponnusamy M, Nandi D. Efficacy of bacteria in cancer immunotherapy: special emphasis on the potential of mycobacterial species. Clin Cancer Drugs. 2016;3:100–08. doi:10.2174/2212697X03666160824130123.
   Google Scholar
• Kubota M, Iizasa E, Chuuma Y, Kiyohara H, Hara H, Yoshida H. Adjuvant activity of Mycobacteria-derived mycolic acids. Heliyon. 2020;6(5):e04064. doi:10.1016/j.heliyon.2020.e04064.
   PubMed Web of Science ®Google Scholar
• Primm TP, Lucero CA, Falkinham JO 3rd. Health impacts of environmental mycobacteria. Clin Microbiol Rev. 2004;17:98–106. doi:10.1128/CMR.17.1.98-106.2004.
   PubMed Web of Science ®Google Scholar
• Wu J, Dalal K. Tuberculosis in Asia and the pacific: the role of socioeconomic status and health system development. Int J Prev Med. 2012;3:8–16.
   PubMedGoogle Scholar
• Walls T, Shingadia D. The epidemiology of tuberculosis in Europe. Arch Dis Child. 2007;92:726–29. doi:10.1136/adc.2006.102889.
   PubMed Web of Science ®Google Scholar
• Aronson NE, Santosham M, Comstock GW, Howard RS, Moulton LH, Rhoades ER, Harrison LH. Long-term efficacy of BCG vaccine in American Indians and Alaska natives: a 60-year follow-up study. Jama. 2004;291:2086–91. doi:10.1001/jama.291.17.2086.
   PubMed Web of Science ®Google Scholar
• Nguipdop-Djomo P, Heldal E, Rodrigues LC, Abubakar I, Mangtani P. BCG vaccination: a long-lasting protection against tuberculosis?–Authors’ reply. Lancet Infect Dis. 2016;16:408–09. doi:10.1016/S1473-3099(16)00134-1.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Subramaniam R, Chen H, Smith A, Keshava S, Shams H. Boosting efferocytosis in alveolar space using BCG vaccine to protect host against influenza pneumonia. PLoS One. 2017;12:e0180143. doi:10.1371/journal.pone.0180143.
   PubMed Web of Science ®Google Scholar
• Moorlag S, Arts RJW, Van Crevel R, Netea MG. Non-specific effects of BCG vaccine on viral infections. Clin Microbiol Infect. 2019;25:1473–78.
   PubMed Web of Science ®Google Scholar
• De Castro MJ, Pardo-Seco J, Martinón-Torres F. Nonspecific (heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis. Clini Infect Dis. 2015;60:1611–19. doi:10.1093/cid/civ144.
   PubMed Web of Science ®Google Scholar
• Uthayakumar D, Paris S, Chapat L, Freyburger L, Poulet H, De Luca K. Non-specific effects of vaccines illustrated through the BCG example: from observations to demonstrations. Front Immunol. 2018;9:2869.
   PubMed Web of Science ®Google Scholar
• Leentjens J, Kox M, Stokman R, Gerretsen J, Diavatopoulos DA, van Crevel R, Rimmelzwaan GF, Pickkers P, Netea MG. BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study. J Infect Dis. 2015;212:1930–38. doi:10.1093/infdis/jiv332.
   PubMed Web of Science ®Google Scholar
• Ozdemir C, Kucuksezer UC, Tamay ZU. Is BCG vaccination affecting the spread and severity of COVID-19? Allergy. 2020;75:1824–27. doi:10.1111/all.14344.
   PubMed Web of Science ®Google Scholar
• Dolgikh S. Further Evidence of a Possible Correlation between the Severity of Covid-19 and BCG Immunization. J Infect Dis Epidemiol 2020; 6:120.
   Google Scholar
• Hamiel U, Kozer E, Youngster I. SARS-CoV-2 rates in BCG-vaccinated and unvaccinated young adults. Jama. 2020;323:2340–41. doi:10.1001/jama.2020.8189.
   PubMed Web of Science ®Google Scholar
• Sekine T, Perez-Potti A, Rivera-Ballesteros O, Strålin K, Gorin JB, Olsson A, Llewellyn-Lacey S, Kamal H, Bogdanovic G, Muschiol S, et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell. 2020;183:158–168.e14. doi:10.1016/j.cell.2020.08.017.
   PubMed Web of Science ®Google Scholar
• Lipsitch M, Grad YH, Sette A, Crotty S. Cross-reactive memory T cells and herd immunity to SARS-CoV-2. Nat Rev Immunol. 2020;20:709–13. doi:10.1038/s41577-020-00460-4.
   PubMed Web of Science ®Google Scholar
• Skendros P, Mitsios A, Chrysanthopoulou A, Mastellos DC, Metallidis S, Rafailidis P, Ntinopoulou M, Sertaridou E, Tsironidou V, Tsigalou C, et al. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J Clin Invest. 2020;130(11):6151–6157.
   Web of Science ®Google Scholar